Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jane Box"'
Autor:
Ellen Goldmuntz, Beverly Welch, Jane Box, Meagan Spychala, Sherrie Callahan, Mary Chester Wasko, Alan Kivitz, Maria Dall'Era, Cynthia Aranow, Karen D. Boyle, Tracy M. Frech, Meggan Mackay, Marcy B. Bolster, Richard M. Keating, Christopher C. Striebich, Betty Diamond, Weiquang Huang, Kate York, John J. Cush, Anne Davidson, William St. Clair, Lynette Keyes-Elstein, Peta-Gay Ricketts, Ewa Olech
Publikováno v:
Rheumatology (Oxford)
Objectives 3-hydroxy-3-methylglutaryl coenzyme-A (HMG Co-A) reductase inhibitors (statins) are standard treatment for hyperlipidaemia. In addition to lipid-lowering abilities, statins exhibit multiple anti-inflammatory effects. The objectives of this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7a586285fdf74b456b6f1c377beef46
https://doi.org/10.1093/rheumatology/kez471
https://doi.org/10.1093/rheumatology/kez471
Autor:
Jane Box, A. Covarrubias, X. Li, Clarence W. Legerton, R. Valente, Robert Wong, Peter Nash, M. Keiserman, Patrick Durez, Rieke Alten, Evgeny Nasonov, Subhashis Banerjee, Gustavo Leon, J. Abraham Simon-Campos, Eduardo Mysler, César Pacheco-Tena, A. Elegbe, Mark C. Genovese
Publikováno v:
The Journal of Rheumatology, Vol. 45, no. 8, p. 1085-1092 (2018)
Objective.To assess 5-year safety, tolerability, and efficacy of subcutaneous (SC) abatacept (ABA) in methotrexate (MTX)-refractory patients with rheumatoid arthritis (RA).Methods.The Abatacept Comparison of sub[QU]cutaneous versus intravenous in Ina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efb749bd44a492cd3ff6d5117bc8d0d7
https://hdl.handle.net/2078.1/222313
https://hdl.handle.net/2078.1/222313
Autor:
David Hagerty, Maxime Dougados, Jane Box, Michael Schiff, Joel M. Kremer, Mark C. Genovese, Tracy Li, Yvonne Sherrer, Jean-Claude Becker, C. Birbara, Michael E. Luggen, Richard Aranda, Kannan Natarajan, Isaac Nuamah
Publikováno v:
New England Journal of Medicine. 353:1114-1123
A substantial number of patients with rheumatoid arthritis have an inadequate or unsustained response to tumor necrosis factor alpha (TNF-alpha) inhibitors. We conducted a randomized, double-blind, phase 3 trial to evaluate the efficacy and safety of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab47d79a454674ce94f55a58c87e7a63
https://doi.org/10.1056/nejmoa050524
https://doi.org/10.1056/nejmoa050524
Autor:
Allison Luo, Carlos Abud-Mendoza, Jane Box, Anthony H. Russell, Edward C. Keystone, Mario Alberto Garza Elizondo, Sheila Gujrathi, Joel M. Kremer, Rene Swanink, Michael E. Luggen, Richard Aranda, Ingrid Delaet
Publikováno v:
Annals of the rheumatic diseases. 71(6)
Objective To assess safety, immunogenicity and efficacy in rheumatoid arthritis (RA) patients switched from long-term intravenous to subcutaneous (SC) abatacept. Methods In this phase IIIb, open-label, single-arm trial, patients who completed ≥4 ye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e40d4fa88cf092acd6e1dacb94791a8b
https://pubmed.ncbi.nlm.nih.gov/22302417
https://pubmed.ncbi.nlm.nih.gov/22302417
Autor:
Edward J. Fudman, James W. Thomas, Jane Box, Robert F. Willkens, Robert G. Berger, Murray B. Urowitz, Donald M. Stablein, Yvonne R. S. Sherrer, Muhammad B. Yunus, Alben G. Goldstein, Frank R. Schmid, N. Paul Hudson, Robert J. R. McKendry, Cara R. Marks, Raye H. Brooks, Theodore W. Rooney, Bernard R. Rubin, Robert L. Wortmann, Justus J. Fiechtner, Allen M. Segal
Publikováno v:
Arthritis & Rheumatism. 35:849-856
Objective. To assess the relative efficacy of methotrexate (MTX), azathioprine (AZA), and their combination in the treatment of rheumatoid arthritis (RA) in a double-blind, prospective, multicenter, controlled trial. Methods. Two hundred nine patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49ce6626cb4c394d6cb3af62711cd527
https://doi.org/10.1002/art.1780350802
https://doi.org/10.1002/art.1780350802
Autor:
Edward Pisko, Kenneth Gallup, Robert Turner, Michael Parker, Abdel-Moshem Nomeir, Jane Box, John Davis, Pat Box, Henry Rothberger
Publikováno v:
Arthritis & Rheumatism. 22:518-523
Sixteen patients with progressive systemic sclerosis were evaluated for cardiopulmonary manifestations of their disease and for serologic immune abnormalities. Twenty-five percent of patients had abnormal echocardiograms, and 81% had a significant re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2313904d7bb0c0311eaf3ae803a5c1d7
https://doi.org/10.1002/art.1780220512
https://doi.org/10.1002/art.1780220512